Neion Bio raised an oversubscribed $23 million Series A to advance its biologics manufacturing platform and expand its pipeline.
- Amount
- $23M
- Stage
- Series A
- Announced
- 11 June 2026
- Lead
- Caffeinated Capital
- Other investors
- Digitalis Ventures, Ensemble VC, Trust Ventures, Haystack, Basis Set Ventures
- Use of funds
- Expand pipeline across biosimilars, innovative medicines, critical reagents, and animal health; develop proprietary rapid-production technologies.
- Checked
- Amount and date matched across 3 press sources